Efficacy and Safety of Initial Versus Delayed Verteporfin Photodynamic Therapy in Combination With Conbercept in Patients With Symptomatic Polypoidal Choroidal Vasculopathy
Phase of Trial: Phase IV
Latest Information Update: 06 Jan 2017
At a glance
- Drugs Conbercept (Primary)
- Indications Choroidal neovascularisation
- Focus Therapeutic Use
- 03 Jan 2017 Status changed from not yet recruiting to recruiting.
- 14 Dec 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Jan 2018.
- 14 Dec 2016 Planned initiation date changed from 1 Jul 2016 to 1 Jan 2017.